Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Bionor Pharma - Fourth Quarter 2014 results

Financial .2015

(Oslo, 25.02.2015) Bionor Pharma ASA (OSE: BIONOR) announced today its financial results for the fourth quarter and preliminary full year 2014 and update on its clinical development program.

Invitation to Webcast of Bionor Pharma Q4 2014 Results 25 February

Financial .2015

Bionor Pharma ASA (OSE:BIONOR) will announce its fourth quarter 2014 results Wednesday 25 February 2015 at 7.00 CET.

Bionor Pharma - Fourth Quarter 2014 results

Financial .2015

(Oslo, 25.02.2015) Bionor Pharma ASA (OSE: BIONOR) announced today its financial results for the fourth quarter and preliminary full year 2014 and update on its clinical development program.

Invitation to Webcast of Bionor Pharma Q4 2014 Results 25 February

Financial .2015

Bionor Pharma ASA (OSE:BIONOR) will announce its fourth quarter 2014 results Wednesday 25 February 2015 at 7.00 CET.

Go to news section

Featured content